C-Raven: Pilot Randomized Controlled Trial (RCT) of an Avatar-delivered Computerized Intervention for Tobacco Cessation With Community Health Worker Linkage to Lung Cancer Screening in Baltimore City

Status: Recruiting
Location: See location...
Intervention Type: Behavioral, Other, Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

In low-income housing units in Baltimore, the investigators propose to conduct a pilot two-arm hybrid type 1 effectiveness-implementation RCT comparing a) an avatar-delivered computerized intervention (CI) for tobacco cessation augmented with CHW support and navigation to lung cancer screening to b) a waitlist control. With a sample of participants from public housing units (N=30), the investigators will collect data on feasibility of recruitment, intervention engagement and completion, and short-term smoking cessation outcomes. Individuals will be assessed at baseline, 1 month, 3 months, and 6 months. At the 3-month time point, the investigators will conduct interviews with a subset of pilot participants to collect qualitative data on intervention acceptability.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:

• Age 50 or older Current tobacco use with \>100 cigarettes smoked in their lifetime

• English speaking (intervention currently in English only and housing units are in largely English-speaking neighborhoods)

• Considering smoking cessation

• Planning to remain in current housing unit for 9 months

Locations
United States
Maryland
Johns Hopkins University School of Medicine
RECRUITING
Baltimore
Contact Information
Primary
Alejandra Ellison-Barnes, MD
aelliso6@jhmi.edu
410-614-1135
Backup
Heidi Hutton, PhD
hhutton@jhmi.edu
(443) 287-2874
Time Frame
Start Date: 2024-10-30
Estimated Completion Date: 2025-10
Participants
Target number of participants: 30
Treatments
Experimental: C-Raven + CHW Smoking Cessation Intervention
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 6 months. Assessments will be conducted at baseline, 1 month, 3 months, and 6 months.
No_intervention: No Intervention
Participants will not receive any intervention during the first 6 months of the study. The participants will receive the study intervention at the end of 6 months, to ensure access to treatment for all participants.
Related Therapeutic Areas
Sponsors
Collaborators: Maryland Cigarette Restitution Fund, Walgreens
Leads: Johns Hopkins University

This content was sourced from clinicaltrials.gov